Pharmaceutical development of IPI-504, an Hsp90 inhibitor and clinical candidate for the treatment of cancer

James R. Porter; Julian Adams; Rebecca Ahn; Vince Ammoscato; Brendan Arsenault; Brian C. Austad; Gary Baker; Johan Basuki; Marlene R. Booth; Matthew J. Campbell; Bennett Carter; Michael Curtis; Kris Depew; Mark A. Douglas; Jie Ge; Louis Grenier; Joseph Helble; John Henderson; Natalie Goltz; Dumitru Ionescu; Laila Kott; Jason T. Kropp; John Lee; Kaiming Li; Bradley Maurer; Denise Mayes; Roger H. Pak; Jason Piotrowski; Jennifer R. Porter; David Rusch; Geoff E. Sylvester; Steven Wong; Jim Wright

作者James R. Porter; Julian Adams; Rebecca Ahn; Vince Ammoscato; Brendan Arsenault; Brian C. Austad; Gary Baker; Johan Basuki; Marlene R. Booth; Matthew J. Campbell; Bennett Carter; Michael Curtis; Kris Depew; Mark A. Douglas; Jie Ge; Louis Grenier; Joseph Helble; John Henderson; Natalie Goltz; Dumitru Ionescu; Laila Kott; Jason T. Kropp; John Lee; Kaiming Li; Bradley Maurer; Denise Mayes; Roger H. Pak; Jason Piotrowski; Jennifer R. Porter; David Rusch; Geoff E. Sylvester; Steven Wong; Jim Wright
卷第71卷
期第7期
印刷ISSN0272-4391
电子ISSN1098-2299
文件大小162.44KB
发表时间2010
DOI10.1002/ddr.20383
页码429-438

发现好书期刊，享受阅读乐趣

Pharmaceutical development of IPI-504, an Hsp90 inhibitor and clinical candidate for the treatment of cancer